AERAS: Form 990, tax year 2014
View the entire original 990 at ProPublica ↗
- Organization
- AERAS (EIN 52-2044704)
- Tax period
- 2014-01-01 to 2014-12-31
- Filed
- 2015-11-15
- IRS object ID
- 201533199349300968
- Schema version
- 2014v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2015-11-15T17:05:04-06:00 | ReturnTs |
| Tax Period End | 2014-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BDO USA LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 8401 GREENSBORO DRIVE 8TH FLOOR | AddressLine1Txt |
| City | MCLEAN | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22102 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2014-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 522044704 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AERAS | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % DONNA D'AMATO | InCareOfNm |
| Business Name Control | AERA | BusinessNameControlTxt |
| Phone | 3015472900 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1405 RESEARCH BLVD SUITE 300 | AddressLine1Txt |
| City | ROCKVILLE | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20850 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Dan Reznikov | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 3015472892 | PhoneNum |
| Signature | 2015-11-13 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Jeffrey J Schragg | PreparerPersonNm |
| PTIN | P00234543 | PTIN |
| Phone | 7038930600 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2014 | TaxYr |
| Build TS | 2016-04-25 22:37:26Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | JACQUELINE LUCAS | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1405 RESEARCH BLVD | AddressLine1Txt |
| City | ROCKVILLE | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20850 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $52,148,139 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.AERAS.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1997 | FormationYr |
| Legal Domicile State | DC | LegalDomicileStateCd |
| Activity Or Mission | DEDICATED TO THE DEVELOPMENT OF EFFECTIVE TUBERCULOSIS (TB) VACCINES & BIOLOGICS TO PREVENT TB ACROSS ALL AGE GROUPS IN AN AFFORDABLE & SUSTAINABLE MANNER. | ActivityOrMissionDesc |
| Voting Members Governing Body | 11 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 10 | VotingMembersIndependentCnt |
| Total Employee | 165 | TotalEmployeeCnt |
| Total Volunteers | 10 | TotalVolunteersCnt |
| Total Gross UBI | $2,521,169 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $53,525,841 | PYContributionsGrantsAmt |
| CY Contributions Grants | $49,605,233 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $1,393,354 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $2,555,918 | CYProgramServiceRevenueAmt |
| PY Investment Income | $116,369 | PYInvestmentIncomeAmt |
| CY Investment Income | $87,258 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$41,122 | PYOtherRevenueAmt |
| CY Other Revenue | -$143,455 | CYOtherRevenueAmt |
| PY Total Revenue | $54,994,442 | PYTotalRevenueAmt |
| CY Total Revenue | $52,104,954 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $1,934,033 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $500,000 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $19,003,953 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $19,875,713 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $27,328,534 | PYOtherExpensesAmt |
| CY Other Expenses | $37,683,490 | CYOtherExpensesAmt |
| PY Total Expenses | $48,266,520 | PYTotalExpensesAmt |
| CY Total Expenses | $58,059,203 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $6,727,922 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$5,954,249 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $51,799,335 | TotalAssetsBOYAmt |
| Total Assets EOY | $45,384,143 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $8,949,247 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $8,493,078 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $42,850,088 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $36,891,065 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | AERAS IS A NON-PROFIT PRODUCT DEVELOPMENT ORGANIZATION DEDICATED TO THE DEVELOPMENT OF EFFECTIVE TUBERCULOSIS (TB) VACCINES AND BIOLOGICS TO PREVENT TB ACROSS ALL AGE GROUPS IN AN AFFORDABLE AND SUSTAINABLE MANNER. AERAS UTILIZES ITS BROAD CAPABILITIES AND TECHNOLOGIES IN COLLABORATION WITH NUMEROUS PARTNERS AND STAKEHOLDERS TO SUPPORT THE DEVELOPMENT OF VACCINES AND OTHER BIOPHARMACEUTICALS TO ADDRESS TB AND OTHER SIGNIFICANT PUBLIC HEALTH NEEDS OF UNDERSERVED POPULATIONS. IN THE PURSUIT OF OUR MISSION, WE ARE GUIDED BY OUR CORE VALUES. THESE CORE VALUES EXPRESS OUR ASPIRATIONS AND THE BEHAVIORS WE WANT TO EXHIBIT AND MODEL. THEY SHAPE THE CULTURE AND CHARACTER OF AERAS AND INFORM ALL OF OUR DECISIONS AND ACTIONS. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $11,631,336 | ExpenseAmt |
| Desc | Preclinical - Aeras develops and assesses a range of vaccine platforms and variations, and explores novel approaches to enhance the effectiveness of new TB vaccines in effective prime-boost regimens. Aeras evaluates TB vaccine candidates to determine whether they have the characteristics needed to move forward to the next phase of development. Key elements include evaluation of safety, immunogenicity and the protection the candidates provide in animal models. An independent panel of vaccine experts evaluates all relevant preclinical data before a candidate is approved for entry into Phase I trials. Aeras also supports the assessment of novel assays that could be implemented at the clinical stage of development to drastically reduce the time and cost of developing new vaccines against tuberculosis. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $19,492,123 | ExpenseAmt |
| Desc | Clinical - Aeras and its research partners have transformed the TB vaccine clinical landscape. Six vaccine candidates are undergoing testing in clinical trials in Kenya, Senegal, South Africa, the United Kingdom, and the United States with support from Aeras for protocol development, safety monitoring, regulatory and immunology. We also design and conduct epidemiology studies to estimate TB prevalence and/or incidence under real-world trial conditions to inform ongoing studies and to assess the feasibility of conducting large-scale clinical trials in TB at additional research sites in TB endemic countries, including China. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $15,031,350 | ExpenseAmt |
| Revenue | $2,555,917 | RevenueAmt |
| Desc | Tech Operations - Vaccine manufacturing facility located at Aeras headquarters designed to manufacture internally developed vaccine candidates based on a range of technology platforms capabilities in bacterial, viral and protein vaccines. Aeras has cGMP-compliant, end-to-end equipment and operating capabilities that meet both US FDA and European EMEA standards. Process development and manufacturing capabilities support translation from research to clinical development, including manufacturing of clinical trial materials for Aeras-sponsored trials. The Facility is also used in collaboration with external vaccine partners and contract product development services clients. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $5,845,506 | TotalOtherProgSrvcExpenseAmt |
| Total Program Service Expenses | $52,000,315 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | false | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | false | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | false | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (true) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| Info In Schedule O Part V | Yes (X) | InfoInScheduleOPartVInd |
| IRP Document | 67 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Employee | 165 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | SF | ForeignCountryCd |
| Foreign Country | HK | ForeignCountryCd |
| Foreign Country | CH | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 11 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 10 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | DONNA D'AMATO | PersonNm |
| Phone | 3015472923 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1405 RESEARCH BLVD STE 300 | AddressLine1Txt |
| City | ROCKVILLE | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20850 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (27 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| Lota Zoth | ||||||||
| Chairman | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Barry Bloom | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| James Connolly | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Marja Esveld | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Peter Hutt | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Marian Jacobs | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Michel Kazatchkine | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Wayne Pisano | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Regina Rabinovich | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Gerd Zettlmeissl | ||||||||
| Director | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Thomas Evans | ||||||||
| President & CEO | 40.0 | 0.0 | Yes (X) | $488,943 | $0 | $35,672 | Yes (X) | |
| ANN GINSBERG | ||||||||
| CMO | 40.0 | 0.0 | $346,087 | $0 | $21,078 | Yes (X) | ||
| JACQUELINE SHEA LUCAS | ||||||||
| COO | 40.0 | 0.0 | $228,873 | $0 | $17,847 | Yes (X) | ||
| WENDY PENRY | ||||||||
| CHRO | 40.0 | 0.0 | $210,147 | $0 | $31,220 | Yes (X) | ||
| DANIEL REZNIKOV | ||||||||
| CFO FROM 5/1/14 | 40.0 | 0.0 | $154,387 | $0 | $8,763 | Yes (X) | ||
| GERARD FLEURY | ||||||||
| CFO THRU 1/14/14 | 40.0 | 0.0 | $95,955 | $0 | $2,686 | Yes (X) | ||
| KEVIN SLY | ||||||||
| VP BD | 40.0 | 0.0 | $278,588 | $0 | $34,869 | Yes (X) | ||
| LEWIS SCHRAGER | ||||||||
| VP Scientific Affairs | 40.0 | 0.0 | $234,530 | $0 | $18,461 | Yes (X) | ||
| KENNETH WALKER | ||||||||
| VP Vaccine Discovery | 40.0 | 0.0 | $223,925 | $0 | $29,173 | Yes (X) | ||
| RITA KHANNA | ||||||||
| General Counsel | 40.0 | 0.0 | $219,543 | $0 | $17,777 | Yes (X) | ||
| KARI STOEVER | ||||||||
| VP EA THRU 9/5/14 | 40.0 | 0.0 | $209,476 | $0 | $18,837 | Yes (X) | ||
| ERIC TSAO | ||||||||
| VP TECH OPS THRU 5/2/14 | 40.0 | 0.0 | $130,084 | $0 | $13,635 | Yes (X) | ||
| SADRITDIN ISHMUKHAMEDOV | ||||||||
| Director thru 11/21/14 | 40.0 | 0.0 | $210,535 | $0 | $16,639 | Yes (X) | ||
| ROBIN GOLDSTEIN | ||||||||
| Sr Dir PM | 40.0 | 0.0 | $244,699 | $0 | $20,129 | Yes (X) | ||
| VICKY CARDENAS | ||||||||
| Dir ESFU thru 12/10/14 | 40.0 | 0.0 | $199,489 | $0 | $20,145 | Yes (X) | ||
| BARBARA SHEPHERD | ||||||||
| Dir Medical Writing | 40.0 | 0.0 | $197,575 | $0 | $21,358 | Yes (X) | ||
| DAVID HOKEY | ||||||||
| Sr Dir Immunology & Animal St | 40.0 | 0.0 | $184,021 | $0 | $20,396 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $3,856,857 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $348,685 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 57 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm | CountryContractorAddress/ForeignAddress/CountryCd | Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd |
|---|---|---|---|---|---|---|---|---|---|---|
| Alexandria Real Estate | ||||||||||
| 385 E Colorado Blvd Suite 299 | PASADENA | CA | 91101 | Landlord | $3,620,245 | |||||
| Quintiles Ltd | ||||||||||
| Clinical | $2,826,375 | PROFESSIONAL SERVICES CENTRE | LIVINGSTON | 0 | UK | EH54 6GA | ||||
| The University of Cape Town | ||||||||||
| Clinical | $1,644,279 | WERNER BEIT SOUTH BUILDING | CAPE TOWN | 0 | SF | EH54 6GA | ||||
| Oregon Health Science University | ||||||||||
| 2525 1st AVENEUE SUITE 120 | PORTLAND | OR | 97207 | Research | $1,578,920 | |||||
| University of Pittsburgh | ||||||||||
| Research | $1,128,367 | |||||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 5 | CntrctRcvdGreaterThan100KCnt |
| Government Grants | $9,809,531 | GovernmentGrantsAmt |
| All Other Contributions | $39,795,702 | AllOtherContributionsAmt |
| Total Contributions | $49,605,233 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | VACCINE MANUFACTURING | Desc |
| Business | 541900 | BusinessCd |
| Total Revenue Column | $2,555,918 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $34,749 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $2,521,169 | UnrelatedBusinessRevenueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $2,555,918 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $80,488 | TotalRevenueColumnAmt |
| Exclusion | $80,488 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Less Rental Expenses LessRentalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $43,134 | RealAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | -$43,134 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$43,134 | TotalRevenueColumnAmt |
| Exclusion | -$43,134 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | $6,821 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $51 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -$51 | SecuritiesAmt |
| Other | $6,821 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $6,770 | TotalRevenueColumnAmt |
| Exclusion | $6,770 | ExclusionAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Other Revenue Misc OtherRevenueMiscGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|---|
| FOREIGN CURRENCY LOSS | 900099 | -$100,390 | -$100,390 | |
| MISCELLANEOUS | 900099 | $69 | $69 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | -$100,321 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $52,104,954 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $34,818 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $2,521,169 | UnrelatedBusinessRevenueAmt |
| Exclusion | -$56,266 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $500,000 | TotalAmt |
| Program Services | $500,000 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,070,552 | TotalAmt |
| Program Services | $2,330,076 | ProgramServicesAmt |
| Management And General | $740,476 | ManagementAndGeneralAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,253,600 | TotalAmt |
| Program Services | $11,790,969 | ProgramServicesAmt |
| Management And General | $1,462,631 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $824,088 | TotalAmt |
| Program Services | $682,963 | ProgramServicesAmt |
| Management And General | $141,125 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,660,983 | TotalAmt |
| Program Services | $1,382,879 | ProgramServicesAmt |
| Management And General | $278,104 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,066,490 | TotalAmt |
| Program Services | $885,071 | ProgramServicesAmt |
| Management And General | $181,419 | ManagementAndGeneralAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $767,738 | TotalAmt |
| Management And General | $767,738 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,726,028 | TotalAmt |
| Program Services | $1,351,401 | ProgramServicesAmt |
| Management And General | $374,627 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,960,723 | TotalAmt |
| Program Services | $3,767,733 | ProgramServicesAmt |
| Management And General | $192,990 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,570,919 | TotalAmt |
| Program Services | $1,357,120 | ProgramServicesAmt |
| Management And General | $213,799 | ManagementAndGeneralAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $389,286 | TotalAmt |
| Program Services | $347,029 | ProgramServicesAmt |
| Management And General | $42,257 | ManagementAndGeneralAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,620,651 | TotalAmt |
| Program Services | $3,400,241 | ProgramServicesAmt |
| Management And General | $220,410 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $308,385 | TotalAmt |
| Program Services | $181,422 | ProgramServicesAmt |
| Management And General | $126,963 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| CONTRACT SERVICES | $19,161,066 | $18,126,322 | $1,034,744 |
| COLLABORATION AGREEMENTS | $2,278,982 | $2,268,244 | $10,738 |
| LAB SUPPLIES AND MATERIALS | $3,206,126 | $3,204,422 | $1,704 |
| TALENT MGMT AND RECRUITMENT | $693,586 | $424,423 | $269,163 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $58,059,203 | TotalAmt |
| Program Services | $52,000,315 | ProgramServicesAmt |
| Management And General | $6,058,888 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $300 | BOYAmt |
| EOY | $300 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $17,445,284 | BOYAmt |
| EOY | $22,674,221 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,039,623 | BOYAmt |
| EOY | $2,611,227 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $46,035 | BOYAmt |
| EOY | $66,333 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $396,807 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,358,123 | BOYAmt |
| EOY | $1,950,848 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $37,752,261 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $31,960,294 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,142,422 | BOYAmt |
| EOY | $5,791,967 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,176,601 | BOYAmt |
| EOY | $11,232,236 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $590,947 | BOYAmt |
| EOY | $660,204 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $51,799,335 | BOYAmt |
| EOY | $45,384,143 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,127,816 | BOYAmt |
| EOY | $5,916,239 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $300,000 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $381,476 | BOYAmt |
| EOY | $760,409 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,439,955 | BOYAmt |
| EOY | $1,516,430 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,949,247 | BOYAmt |
| EOY | $8,493,078 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,057,549 | BOYAmt |
| EOY | $5,117,193 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $35,792,539 | BOYAmt |
| EOY | $31,773,872 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $42,850,088 | BOYAmt |
| EOY | $36,891,065 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $51,799,335 | BOYAmt |
| EOY | $45,384,143 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$5,954,249 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$4,774 | NetUnrlzdGainsLossesInvstAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Medical Research Organization | Yes (X) | MedicalResearchOrganizationInd |
Hospital Name And Address HospitalNameAndAddressGrp (11 entries)
| CityCityNm | State AbbreviationStateAbbreviationCd |
|---|---|
| JOHNS HOPKINS | |
| BALTIMORE | MD |
| ST LOUIS | |
| ST LOUIS | MO |
| OREGON HEALTH | |
| PORTLAND | OR |
| NEW YORK UNIVERSITY | |
| NEW YORK | NY |
| ALBERT EINSTEIN COLLEGE OF MEDICINE | |
| NEW YORK | NY |
| UNIVERSITY OF ROCHESTER | |
| ROCHESTER | NY |
| MASSACHUSETTS GENERAL HOSPITAL | |
| CONCORD | MA |
| UNIVERSITY OF PITTSBURG | |
| PITTSBURG | PA |
| VACCINE RESEARCH CENTER AT NIH | |
| BETHESDA | MD |
| UNIVERSITY OF MASSACHUSETTS SCHOOL OF MEDICINE | |
| WORCESTER | MA |
| FRED HUTCHINSON CANCER RESEARCH CENTER | |
| SEATTLE | WA |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp | |
| CY Minus3 Yr Endwmt Fund | CYMinus3YrEndwmtFundGrp | |
| CY Minus4 Yr Endwmt Fund | CYMinus4YrEndwmtFundGrp | |
| Land | LandGrp |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Cost Or Other Basis | $0 | InvestmentCostOrOtherBasisAmt |
| Other Cost Or Other Basis | $18,124,057 | OtherCostOrOtherBasisAmt |
| Depreciation | $14,010,763 | DepreciationAmt |
| Book Value | $4,113,294 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Cost Or Other Basis | $0 | InvestmentCostOrOtherBasisAmt |
| Other Cost Or Other Basis | $165,615 | OtherCostOrOtherBasisAmt |
| Depreciation | $134,536 | DepreciationAmt |
| Book Value | $31,079 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Cost Or Other Basis | $0 | InvestmentCostOrOtherBasisAmt |
| Other Cost Or Other Basis | $16,307,290 | OtherCostOrOtherBasisAmt |
| Depreciation | $14,904,412 | DepreciationAmt |
| Book Value | $1,402,878 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Investment Cost Or Other Basis | $0 | InvestmentCostOrOtherBasisAmt |
| Other Cost Or Other Basis | $3,155,299 | OtherCostOrOtherBasisAmt |
| Depreciation | $2,910,583 | DepreciationAmt |
| Book Value | $244,716 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $5,791,967 | TotalBookValueLandBuildingsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| DEFERRED RENT | $1,425,672 |
| DEFERRED 457 PLAN | $90,758 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $1,516,430 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $49,560,733 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$4,775 | NetUnrealizedGainsInvstAmt |
| Other Revenue | -$26,662 | OtherRevenueAmt |
| Revenue Not Reported | -$31,437 | RevenueNotReportedAmt |
| Revenue Subtotal | $49,592,170 | RevenueSubtotalAmt |
| Other Revenues Not Included | $2,512,784 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | $2,512,784 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $52,104,954 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $43,227,774 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $199,922 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $199,922 | ExpensesNotReportedAmt |
| Expenses Subtotal | $43,027,852 | ExpensesSubtotalAmt |
| Other Expenses Not Included | $15,031,351 | OtherExpensesNotIncludedAmt |
| Expenses Not Rpt Fincl Stmt | $15,031,351 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $58,059,203 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| OTHER REVENUE ON BOOKS BUT NOT ON RETURN | Income of Affiliate $ 3,036,825 Eliminations $ (3,063,487) --------------- Total $ (26,662) |
| OTHER EXPENSES ON BOOKS BUT NOT ON RETURN | Expenses of Affiliate $ 3,220,275 Eliminations $ (3,063,487) Reclassed Rental Expense $ 43,134 ----------------- $ 199,922 |
| FIN 48 FOOTNOTE | In accordance with authoritative guidance issued by the FASB, Aeras would recognize a tax liability when, despite management's belief that tax return positions are supportable, management believes that certain positions may not be fully sustained upon review by tax authorities. Liabilities for uncertain tax positions would be measured based upon the largest liability that is greater than 50% likely to be incurred on any settlement with taxing authorities. To the extent that the final tax outcome of these matters would differ from the liabilities recorded, such differences would be included in income tax expense in the period in which such determination is made. Interest and penalties, if any, related to accrued liabilities for potential tax assessments also would be included in income tax expense. Management has evaluated Aeras' tax positions and has concluded that Aeras has taken no material uncertain tax positions that require adjustment to the consolidated financial statements to comply with the provisions of this guidance. Aeras is currently under no income tax examinations in any Federal, or state or local jurisdictions. Aeras is generally no longer subject to income tax examinations by the U.S. federal, state or local tax authorities for years ended December 31, 2010 and prior. |
| OTHER REVENUE ON RETURN BUT NOT ON BOOKS | Reclassed Rental Income $ 0 Reclassed Rental Expense $ (43,134) Income from Discontinued Operations $ 2,555,918 ------------------- $ 2,512,784 |
| OTHER EXPENSES ON RETURN NOT ON BOOKS | Loss from Discontinued Operations $ 15,031,351 ------------------- Total $ 15,031,351 |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt | OfficesOfficesCnt | EmployeeEmployeeCnt |
|---|---|---|---|---|---|
| East Asia and the Pacific | Program Services | PRECLINICAL | $744,023 | ||
| Europe | Program Services | PRECLINICAL | $1,158,047 | ||
| Sub-Saharan Africa | Program Services | CLINICAL | $9,096,301 | ||
| East Asia and the Pacific | Program Services | PRECLINICAL | $456,434 | 1 | 3 |
| Sub-Saharan Africa | Program Services | CLINICAL | $2,448,217 | 1 | 21 |
| Europe | Grant | PRECLINICAL | $500,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 2 | SubtotalOfficesCnt |
| Subtotal Employees | 24 | SubtotalEmployeesCnt |
| Total Office | 2 | TotalOfficeCnt |
| Total Employee | 24 | TotalEmployeeCnt |
| Subtotal Spent | $14,403,022 | SubtotalSpentAmt |
| Total Spent | $14,403,022 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | Europe (Including Iceland and Greenland) | RegionTxt |
| Purpose Of Grant | SEE PART V | PurposeOfGrantTxt |
| Cash Grant | $500,000 | CashGrantAmt |
| Manner Of Cash Disbursement | EFT | MannerOfCashDisbursementTxt |
| Valuation Method Used | CASH | ValuationMethodUsedDesc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 1 | Total501c3OrgCnt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, SCHEDULE F, PART I, LINE 2 | Aeras receives a request for support. Senior management reviews the request through the due diligence criteria approved by the Board and implemented by management. For example, the grantee must be a charity either under US law or under local law. Aeras may request governance documents from the organization, IRS determination letter (or local equivalent) indicating it is a charity, lists of executive staff and board members, and financial statements of the requestor. Upon management approval, funds are sent to the requesting organization. Copies of the request and payment are maintained at Aeras. |
| FORM 990, SCHEDULE F, PART II, COLUMN (D) | The purpose of the grant is to provide support to Clinical and Preclinical projects such as MTBVAC, HBHA VPM, UOX and ChAd. |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| First Class Or Charter Travel | Yes (X) | FirstClassOrCharterTravelInd |
| Housing Allowance Or Residence | Yes (X) | HousingAllowanceOrResidenceInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (true) | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (15 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thomas Evans | |||||||||||||
| President & CEO | $488,943 | $0 | $0 | $0 | $0 | $0 | $15,600 | $0 | $20,072 | $0 | $524,615 | $0 | $0 |
| ANN GINSBERG | |||||||||||||
| CMO | $341,987 | $0 | $4,100 | $0 | $0 | $0 | $15,600 | $0 | $5,478 | $0 | $367,165 | $0 | $0 |
| JACQUELINE SHEA LUCAS | |||||||||||||
| COO | $228,873 | $0 | $0 | $0 | $0 | $0 | $7,200 | $0 | $10,647 | $0 | $246,720 | $0 | $0 |
| WENDY PENRY | |||||||||||||
| CHRO | $206,147 | $0 | $4,000 | $0 | $0 | $0 | $12,454 | $0 | $18,766 | $0 | $241,367 | $0 | $0 |
| DANIEL REZNIKOV | |||||||||||||
| CFO FROM 5/1/14 | $154,387 | $0 | $0 | $0 | $0 | $0 | $5,769 | $0 | $2,994 | $0 | $163,150 | $0 | $0 |
| KEVIN SLY | |||||||||||||
| VP BD | $274,888 | $0 | $3,700 | $0 | $0 | $0 | $15,600 | $0 | $19,269 | $0 | $313,457 | $0 | $0 |
| LEWIS SCHRAGER | |||||||||||||
| VP Scientific Affairs | $234,530 | $0 | $0 | $0 | $0 | $0 | $13,800 | $0 | $4,661 | $0 | $252,991 | $0 | $0 |
| KENNETH WALKER | |||||||||||||
| VP Vaccine Discovery | $220,525 | $0 | $3,400 | $0 | $0 | $0 | $13,311 | $0 | $15,862 | $0 | $253,098 | $0 | $0 |
| RITA KHANNA | |||||||||||||
| General Counsel | $216,743 | $0 | $2,800 | $0 | $0 | $0 | $12,688 | $0 | $5,089 | $0 | $237,320 | $0 | $0 |
| SADRITDIN ISHMUKHAMEDOV | |||||||||||||
| Director thru 11/21/14 | $207,135 | $0 | $3,400 | $0 | $0 | $0 | $0 | $0 | $16,639 | $0 | $227,174 | $0 | $0 |
| KARI STOEVER | |||||||||||||
| VP EA THRU 9/5/14 | $205,476 | $0 | $4,000 | $0 | $0 | $0 | $11,224 | $0 | $7,613 | $0 | $228,313 | $0 | $0 |
| ROBIN GOLDSTEIN | |||||||||||||
| Sr Dir PM | $242,099 | $0 | $2,600 | $0 | $0 | $0 | $14,511 | $0 | $5,618 | $0 | $264,828 | $0 | $0 |
| VICKY CARDENAS | |||||||||||||
| Dir ESFU thru 12/10/14 | $196,889 | $0 | $2,600 | $0 | $0 | $0 | $10,451 | $0 | $9,694 | $0 | $219,634 | $0 | $0 |
| BARBARA SHEPHERD | |||||||||||||
| Dir Medical Writing | $194,675 | $0 | $2,900 | $0 | $0 | $0 | $11,485 | $0 | $9,873 | $0 | $218,933 | $0 | $0 |
| DAVID HOKEY | |||||||||||||
| Sr Dir Immunology & Animal St | $180,621 | $0 | $3,400 | $0 | $0 | $0 | $10,708 | $0 | $9,688 | $0 | $204,417 | $0 | $0 |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, LINE 11B | A draft version of the Form 990 is shared with the Board of Directors of Aeras and once approved it is filed with the IRS. |
| FORM 990, PART VI, LINE 12C | Aeras' policy is written to protect Aeras' interest when it is contemplating entering into a transaction or arrangement that might benefit the private interest of directors, committee members, officers, employees and retained consultants of Aeras. In connection with any actual or possible conflicts of interest, an interested person must disclose the existence of his or her interest and all material facts to the directors and members of the committee with board-delegated powers considering the proposed transaction or arrangement. After disclosure of all material facts and discussion with the person, the person shall leave the board or committee meeting while their determination of a conflict of interest is discussed and voted upon. The remaining board or committee members shall decide if a conflict of interest exists. |
| FORM 990, PART VI, LINE 15 | Aeras has a Compensation Committee which determines the CEO compensation level based on his responsibilities, size of the organization, funding levels and organization objectives. Compensation is based on comparability data, is approved by independent Board members, and the process is documented in the Board minutes. Compensation for other officers is determined by the CEO, based on the officer's responsibilities, funding levels and organization objectives. compensation is based on comparability data and is shared with independent board members. |
| FORM 990, PART VI, LINE 19 | Governing documents, including Articles of Incorporation, Bylaws, Board minutes, Conflict of Interest policy and financial statements are available upon request. |
| FORM 990, PART III, LINE 4D | Aeras also works to build relationships that support its goal to develop TB vaccines through collaboration at the global and regional levels with multi-lateral organizations such as the European Union, the European Investment Bank, and the World Health Organization, among other TB researchers and vaccine developers, as well as with donors, advocates and policymakers who can help raise awareness and support for this work. Aeras' Scientific and External Affairs departments are critical to advancing these strategic partnerships to ensure global support. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AERAS SOUTH AFRICA | BusinessNameLine1Txt |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | BLACKRIVER PARK 1ST FLR | AddressLine1Txt |
| City | CAPE TOWN | CityNm |
| Province Or State | OBSERVATORY | ProvinceOrStateNm |
| Country | SF | CountryCd |
| Foreign Postal | 7925 | ForeignPostalCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Primary Activities | CLINICAL TR | PrimaryActivitiesTxt |
| Legal Domicile Foreign Country | SF | LegalDomicileForeignCountryCd |
| Exempt Code Section | N/A | ExemptCodeSectionTxt |
| Public Charity Status | N/A | PublicCharityStatusTxt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | NA | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Controlled Organization | Yes (true) | ControlledOrganizationInd |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (2 entries)
| Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Entity TypeEntityTypeTxt | Share Of Total IncomeShareOfTotalIncomeAmt | Share Of EOY AssetsShareOfEOYAssetsAmt | OwnershipOwnershipPct | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|
| AERAS HONG KONG | ||||||||||
| UNIT 1618 16/F MIRAMAR TOWER | KOWLOON | HK | Holding Company | HK | Aeras | C Corp | -$5,827 | $431,937 | 1.00000 | Yes (true) |
| Aeras Beijing Biological Tech Co Ltd | ||||||||||
| Unit 1446 14F A Tower Pacific | Beijing | CH | Consulting | CH | Aeras Hong Kong | C Corp | -$211,721 | $142,221 | 1.00000 | Yes (true) |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | false | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (true) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | false | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (2 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| Aeras South Africa | ||
| M | $2,889,359 | Cash |
| Aeras Beijing Biological Tech Co Ltd | ||
| M | $174,128 | Cash |
Comments